Edwards Lifesciences said on August 19, 2025 it executed an accelerated share repurchase agreement to repurchase $500 million of its common stock.

8-KOther EventsFiled Aug 19, 2025Period of report Aug 19, 2025Summary published (UTC) Oct 13, 2026

Key points

AI summary

Edwards Lifesciences said on August 19, 2025 it executed an accelerated share repurchase agreement to repurchase $500 million of its common stock.
Under the terms of the ASR, the company said it will receive an initial delivery of approximately 5 million shares and the remainder at the maturity of the ASR. It added that the final number of shares to be repurchased will be based on the volume weighted average share price during the term of the agreement.
Edwards Lifesciences said it is funding the ASR with its existing cash.
The company said that with this transaction, it has repurchased more than $800 million of shares in 2025. It added that following this repurchase, approximately $600 million remains in its share repurchase authorization approved by its Board of Directors.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

$500 million Accelerated Share Repurchase Agreement Executed

Edwards Lifesciences said on August 19, 2025 it executed an accelerated share repurchase agreement to repurchase $500 million of its common stock.

Source · Based on the filing body and exhibits

Initial Delivery of Approximately 5 million Shares and Remainder at ASR Maturity

Under the terms of the ASR, the company said it will receive an initial delivery of approximately 5 million shares and the remainder at the maturity of the ASR. It added that the final number of shares to be repurchased will be based on the volume weighted average share price during the term of the agreement.

Source · Based on the filing body and exhibits

ASR Funded with Existing Cash

Edwards Lifesciences said it is funding the ASR with its existing cash.

Source · Based on the filing body and exhibits

2025 Cumulative Share Repurchases and Remaining Board-Approved Authorization

The company said that with this transaction, it has repurchased more than $800 million of shares in 2025. It added that following this repurchase, approximately $600 million remains in its share repurchase authorization approved by its Board of Directors.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.